Alissa Martin
Overview
Explore the profile of Alissa Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yankelevich M, Thakur A, Modak S, Chu R, Taub J, Martin A, et al.
J Immunother Cancer
. 2024 Mar;
12(3).
PMID: 38519053
Background: The survival benefit observed in children with neuroblastoma (NB) and minimal residual disease who received treatment with anti-GD2 monoclonal antibodies prompted our investigation into the safety and potential clinical...
2.
Yankelevich M, Thakur A, Modak S, Chu R, Taub J, Martin A, et al.
Res Sq
. 2023 Nov;
PMID: 37986911
Background: Since treatment of neuroblastoma (NB) with anti-GD2 monoclonal antibodies provides a survival benefit in children with minimal residual disease and our preclinical study shows that anti-CD3 x anti-GD2 bispecific...
3.
Regling K, Pomerantz D, Narayanan S, Altinok D, Sivaswamy L, Marupudi N, et al.
J Pediatr Hematol Oncol
. 2019 Dec;
43(1):e95-e98.
PMID: 31789782
Reversible cerebral vasoconstriction syndrome (RCVS), is rare in the pediatric population and is characterized by severe headaches and other neurologic symptoms. We present a case of RCVS occurring concomitantly with...
4.
Messinger Y, Boklan J, Goldberg J, Dubois S, Oesterheld J, Abla O, et al.
Pediatr Hematol Oncol
. 2017 Oct;
34(4):187-198.
PMID: 29039989
Relapsed/refractory acute myeloid leukemia (AML) has an extremely poor prognosis. We describe 17 children and adolescents with relapsed/refractory AML who received clofarabine, cyclophosphamide, and etoposide. Seven patients (41%) responded: 4...
5.
Hutchins K, Ross R, Kobayashi D, Martin A, Rajpurkar M
J Pediatr Hematol Oncol
. 2017 Sep;
39(7):e391-e393.
PMID: 28859030
Infantile hemangioma is a benign vascular neoplasm that spontaneously involutes over time. Management, when needed, consists of medications, laser treatment and surgical excision. We describe a 3-year-old girl who presented...
6.
Montoya V, Fan H, Bryar P, Weinstein J, Mets M, Feng G, et al.
PLoS One
. 2015 Sep;
10(9):e0138366.
PMID: 26379276
Retinoblastoma is the most common intraocular tumor in children. Current management includes broad-based treatments such as chemotherapy, enucleation, laser therapy, or cryotherapy. However, therapies that target specific pathways important for...
7.
Ozgonenel B, Martin A
Pediatr Blood Cancer
. 2015 Jul;
62(11):2054-5.
PMID: 26132912
No abstract available.
8.
Martin A, Schneiderman J, Helenowski I, Morgan E, Dilley K, Danner-Koptik K, et al.
Pediatr Blood Cancer
. 2014 Mar;
61(8):1350-6.
PMID: 24634399
Background: Outcomes for high-risk neuroblastoma remain poor. Modern treatment protocols utilizing intense induction followed by myeloablative consolidation chemotherapy with autologous stem cell rescue (ASCR) have improved survival rates, but the...
9.
Martin A, Thompson A
Pediatr Clin North Am
. 2013 Nov;
60(6):1383-91.
PMID: 24237977
The thalassemia syndromes are hemoglobin disorders that result from significantly reduced or absent synthesis of either the α- or β-globin chains. The result is a chronic hemolytic anemia with ineffective...
10.
Martin A, Jones A, Bryar P, Mets M, Weinstein J, Zhang G, et al.
Biochem Biophys Res Commun
. 2013 Oct;
440(4):599-603.
PMID: 24120948
Retinoblastoma is the most common pediatric cancer of the eye. Currently, the chemotherapeutic treatments for retinoblastoma are broad-based drugs such as vincristine, carboplatin, or etoposide. However, therapies targeted directly to...